AGT and osteoporosis: Regarding the bone tissue, available clinical, in vivo, and cellular data strongly suggest that RAS activation plays a role in bone deterioration associated with metabolic disorders such as osteoporosis, arthritis, bone, risk fracture, and fracture healing, due to the increased activity of AngII acting via AT1R [6,7,8,9].